<?xml version="1.0" encoding="UTF-8"?>
<ref id="B51-jcm-09-01909">
 <label>51.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nikolic</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Banach</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Chianetta</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Luzzu</surname>
    <given-names>L.M.</given-names>
   </name>
   <name>
    <surname>Pantea Stoian</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Diaconu</surname>
    <given-names>C.C.</given-names>
   </name>
   <name>
    <surname>Citarrella</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Montalto</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Rizzo</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>An overview of statin-induced myopathy and perspectives for the future</article-title>
  <source>Expert Opin. Drug Saf.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1080/14740338.2020.1747431</pub-id>
  <?supplied-pmid 32233708?>
  <pub-id pub-id-type="pmid">32233708</pub-id>
 </element-citation>
</ref>
